Abstract:Background Fistulae represent a frequent complication in Crohn's disease (CD).Surgical resection is often required, as medical treatment outcome with conventional drugs is often insufficient.We have previously demonstrated that epithelial-to-mesenchymal transition (EMT) plays a critical role for fistula development.The T cell cytokines tumor necrosis factor (TNF), interleukin (IL)-13, interferon (IFN) g, IL-17A and IL-22 are highly expressed in transitional cells along fistula tracts in CD patients.Similar to transforming growth factor (TGF) b, TNF is able to induce EMT and the expression of molecules being associated with cell invasiveness and migration.IL-13 has no impact on epithelial cell morphology, but also induces expression of genes being associated with invasive cell growth, such as SLUG transcription factor and b6-integrin.Here, we analyzed the implication of the T cell-derived cytokines IFNg, IL-17A and IL-22 in the event of EMT.Moreover, we investigated if there are differences in the composition of lymphocytes in the blood of CD patients suffering from fistulae compared to patients without fistulae or healthy controls.Methods Threedimensional intestinal epithelial cell (IEC) constructs (spheroids) were stimulated with IFN g, IL-17A and IL-22 to investigate the effects on EMT development.Further, CD4+ and CD25+ T cells were isolated from fistulizing CD patients' blood or control blood samples and cocultured together with HT29 cells.Afterwards, mRNA expression levels of EMT-associated genes were analyzed.Results Treatment of the in vitro spheroid model with IFNg resulted in a loss of the well-defined globular spheroid shape after day 7.We observed a clear separation of IECs, while mRNA levels for EMT-related transcription factors like SNAIL-1 and ETS-1 were not up-regulated.IL-17A and IL-22 had no effect on cell morphology suggesting that they do not induce EMT in our cell model.On a molecular level, both cytokines had no effect on the mRNA expression of EMT-associated genes, but prevented the TGFb-induced up-regulation of e.g.SNAIL-1 or ETS-1.The sorting of T cells isolated from blood of CD patients with fistulae revealed an elevated expression level of CD4+ and CD25+ T cells compared to healthy controls.Conclusions Our data demonstrate that T cell derived cytokines may play a crucial role in the pathogenesis of CD-associated fistulae.Th1 cell-derived IFNg may be involved in the event of EMT in IECs, however Th17 cellderived cytokines IL-17A and IL-22 are likely not implicated in EMT onset, and may prevent EMT-associated effects of TGFb.This observation supports the hypothesis that Th17 cellderived cytokines exert a pivotal role for maintaining intestinal homeostasis.The different lymphocyte composition in CD patients' blood represents a further hint for the importance of these cells in fistulae formation.

The clinical care of adult patients with sickle cell disease.

OP31 Single-cell analyses identify immune and stromal signatures of perianal fistulizing Crohn's Disease

Single-Cell and Spatial Multi-omics Reveal Interferon Signaling in the Pathogenesis of Perianal Fistulizing Crohn's Disease

P199 Analysis of Clinical Features of Asymptomatic Perianal Fistulizing Crohn’s Disease

P097 Spatially resolved insights into fistulating Crohn's disease pathogenesis: Unveiling molecular heterogeneity

Spatial single cell profiling using imaging mass cytometry - inflammatory versus penetrating Crohn’s disease

Digital quantum memories with symmetric pulses.

Etiology of perianal Crohn's disease: role of genetic, microbiological, and immunological factors

P055 GPR43 and GPR84 play a crucial role in supporting perianal fistula formation and disease progression in Crohn’s Disease

Chorismate mutase/prephenate dehydrogenase from Escherichia coli K12: purification, characterization, and identification of a reactive cysteine.

Role of Microbiome in the Outcomes Following Surgical Repair of Perianal Fistula: Prospective Cohort Study Design and Preliminary Results

P126 Differential granulocyte populations as therapeutic targets in fistula

Sa1852 Computational Prediction and Validation of UPF1 As a Novel Molecule for Ulcerative Colitis

Perianal Fistulizing Crohn's Disease: Outcomes of Surgical Repairs and Current State of Stem Cell-Based Therapies

Perianal Fistula-Associated Carcinoma in Crohn's Disease: A Multicentre Retrospective Case Control Study

Human adipose-derived mesenchymal stromal cells improved wound healing in enterocutaneous fistulizing disease mouse model

Electromagnetic Scattering From an Arbitrarily Shaped Bi-Isotropic Body of Revolution

NUTRITION THERAPY IN SEPSIS: CHARACTERIZATION AND IMPLICATIONS FOR CLINICAL PROGNOSIS.

Advanced Regenerative Medicine Strategies for Treatment of Perianal Fistula in Crohn's Disease

Efficacy and safety of allogeneic umbilical cord-derived mesenchymal stem cells for the treatment of complex perianal fistula in Crohn’s disease: a pilot study

Perianal fistulizing Crohn's disease: Current perspectives on diagnosis, monitoring and management with a focus on emerging therapies